Endocrinology News

Using a pod-based automated insulin delivery system can provide glycemic benefits for people with type 2 diabetes, according to a speaker at the International Conference on Advanced Technologies & Treatments for Diabetes.

A slew of new medications currently in development may allow health care providers to go beyond glycemic management in the treatment of type 2 diabetes, according to a speaker.

Adults with a higher BMI and waist-to-hip ratio may be more likely to report worse depression, according to study findings published in PLOS ONE.

The FDA cleared for marketing an over-the-counter continuous glucose monitor for adults with or without diabetes, according to an agency press release.

Among pregnant women with type 1 diabetes, more time in optimal glucose range at 12 weeks gestation was associated with lower risks for preeclampsia and large for gestational age infants, researchers reported.

Adults with osteoporosis who received a full course of denosumab were less likely to develop incident diabetes than those who discontinued denosumab after the initial dose, according to study data published in JAMA Network Open.

Shorter sleep durations increased the risk for developing type 2 diabetes, even among those with healthy eating habits, research showed.

The FDA approved the first two denosumab biosimilars.

Adults with type 2 diabetes and chronic kidney disease have a 24% lower risk for kidney disease progression and cardiovascular and kidney mortality with once-weekly semaglutide 1 mg, according to topline results from the FLOW trial.

Men who had a lower birth weight followed by overweight during young adulthood have a greatly increased risk for developing type 2 diabetes vs. those with normal weight at those times, according to study results published in Diabetologia.